Brian Lasonde

Mgh Institute of Health Professions - Boston / United States

Medical and Health Sciences / Hematology

AD Scientific Index ID: 4772551

Registration, Add Profile,
Premium Membership

Print Your Certificate

Brian Lasonde's MOST POPULAR ARTICLES

1-) ENMD-2076, an oral inhibitor of angiogenic and proliferation kinases, has activity in recurrent, platinum resistant ovarian cancer UA Matulonis, J Lee, B Lasonde, WP Tew, A Yehwalashet, D Matei, ... European journal of cancer 49 (1), 121-131, 2013 382013

2-) A phase II trial of iniparib (BSI-201) in combination with gemcitabine/carboplatin (GC) in patients with platinum-sensitive recurrent ovarian cancer.RT Penson, C Whalen, B Lasonde, CN Krasner, P Konstantinopoulos, ...Journal of Clinical Oncology 29 (15_suppl), 5004-5004, 2011

3-) Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC).U Matulonis, GM Wulf, MJ Birrer, SN Westin, P Quy, KM Bell-McGuinn, ...Journal of Clinical Oncology 32 (15_suppl), 2510-2510, 2014

4-) Abstract OT1-4-02: Phase I study of the combination of BKM120 and olaparib for the treatment of high grade serous ovarian cancer (HGSC) and triple negative breast cancer (TNBC)UA Matulonis, G Wulf, L Cantley, G Mills, B Lasonde, T Atkinson, ...Cancer Research 73 (24_Supplement), OT1-4-02-OT1-4-02, 201312013

5-) Opioid and Adjunctive Medication Prescriptions in Curative-Intent Radiation Therapy for Head and Neck Cancer (HNC)S Khan, R Lu, B Lasonde, S HawaInternational Journal of Radiation Oncology, Biology, Physics 118 (5), e54-e55, 20242024

ARTICLES

Add your articles